CCR7 and rheumatoid arthritis: Preventive or therapeutic treatment of humanized CCR7 mice with anti-human CCR7 mAb 8H3-16A12 can restrain or relieve the rheumatoid arthritis mouse model effectually due to the weakened migration of DCs (Moschovakis et al., 2019).